| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,256,800 | 1,523,200 | 1,727,700 | 1,724,300 | | Cost of Revenue | 884,800 | 1,041,000 | 1,170,000 | 1,163,500 | | | Gross Profit | 372,000 | 482,200 | 557,700 | 560,800 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 256,900 | 270,900 | 307,800 | 314,400 | | Non Recurring | 8,800 | 52,400 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 106,300 | 158,900 | 249,900 | 246,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 106,300 | 158,900 | 249,900 | 246,400 | | Interest Expense | 15,200 | 19,900 | 17,300 | 18,300 | | Income Before Tax | 91,100 | 139,000 | 232,600 | 228,100 | | Income Tax Expense | 9,900 | 27,900 | 43,400 | 66,200 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 81,200 | 111,100 | 189,200 | 161,900 | | | Non-recurring Events | | Discontinued Operations | 18,900 |
-
| 16,600 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 100,100 | 111,100 | 205,800 | 161,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $100,100 | $111,100 | $205,800 | $161,900 |
|
0.45% Nasdaq 
0.20%
Income Statement
